Frazier Healthcare's PCI buys Biotec

PCI, a portfolio company of Frazier Healthcare, said Friday that it has acquired Biotec. No financial terms were disclosed. Teneo Capital provided financial advice to PCI and Frazier Healthcare for this transaction. Based in the UK, Biotec is a provider of clinical trial services and temperature controlled pharmaceutical solutions.

19 September 2014•6 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles